Cleared Special

K011837 - LIFECARD CF 7 DAY

K011837 is an FDA 510(k) clearance for LIFECARD CF 7 DAY, manufactured by Reynolds Medical , Ltd.. The device is a Class 2 Cardiovascular device with product code MWJ cleared through the Special 510(k) pathway after a 31-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2001
Decision
31d
Days
Class 2
Risk

K011837 is an FDA 510(k) clearance for the LIFECARD CF 7 DAY. Classified as Electrocardiograph, Ambulatory (without Analysis) (product code MWJ), Class II - Special Controls.

Submitted by Reynolds Medical , Ltd. (Hasbrouck, US). The FDA issued a Cleared decision on July 13, 2001 after a review of 31 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2800 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K011837

510(k) Number K011837 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2001
Decision Date July 13, 2001
Days to Decision 31 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 125d · This submission: 31d
Pathway characteristics
Modification to existing cleared device.

MWJ Device Classification - Class 2, Special Controls

Product Code MWJ Electrocardiograph, Ambulatory (without Analysis)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWJ Electrocardiograph, Ambulatory (without Analysis)

All 63
Devices cleared under the same product code (MWJ) and FDA review panel - the closest regulatory comparables to K011837.
ER800 SERIES ECG EVENT RECORDER
K030856 · Braemar Corp. · Mar 2003
SEER LIGHT COMPACT DIGITAL HOLTER RECORDER
K021470 · General Electric Medical Systems Information Techn · Nov 2002
H12+HOLTER RECORDER
K021373 · Mortara Instrument, Inc. · Jun 2002
CARDIONET AMBULATORY ECG MONITOR, MODEL CN1000A
K003707 · Cardionet · May 2001
NEXAN SYSTEM, MODEL NX-300
K003520 · Nexan, Ltd. · Dec 2000
CARDIOVISE ECG INTERPRETATIVE SOFTWARE
K001349 · Inovise Medical, Inc. · Jul 2000